Ewert, Ralf
Ittermann, Till
Habedank, Dirk http://orcid.org/0000-0003-3403-7146
Held, Matthias
Lange, Tobias J.
Halank, Michael
Winkler, Jörg
Gläser, Sven
Olschewski, Horst
Kovacs, Gabor
Article History
Received: 13 April 2019
Accepted: 20 November 2019
First Online: 29 November 2019
Ethics approval and consent to participate
: The study was approved by the ethics committee of Greifswald University (No. 043/13a, study protocol and amendment of May 5th, 2015). Our study was a retrospective analysis of patients with SSc from a prevalent cohort. This was not a healthcare intervention trial. The data were analysed with the informed, written consent of all patients.
: The manuscript does not contain data from any individual person in any form.
: GK: personal fees and non-financial support from Actelion, Bayer, GSK, MSD, Pfizer, AOP, Boehringer Ingelheim, Novartis, ChiesiDH, JW and TI: noneMHe: research funding and grant from Actelion; honoraria for lectures from Actelion, Bayer Healthcare, Berlin Chemie, Boehringer Ingelheim, Daichii Sankyo, GSK, MSD, Novartis, Pfizer; participation in clinical trials from Actelion, Bayer, GSK, Pfizer, United Therapeutics; Honoraria for Advisory Boards from Actelion, Bayer, Boehringer, GSK, MSDHO: grants from Actelion, Boehringer, MSD, Inventiva; personal fees from Actelion, Bayer, Boehringer, Chiesi, GSK, Menarini, MSD; non-financial support from Actelion, Bayer, Boehringer, GSK, Menarini, MSDSG: personal fees from Boehringer, Roche, Novartis, Berlin Chemie; non-financial support from ActelionMHa: personal fees and non-financial support from Actelion, Bayer, GSK, MSD, Novartis, Berlin Chemie, OMT, AstraRE: Grant and lecture fee from Actelion; grants from United Therapeutics, OMT, Boehringer; personal fees from Actelion, Bayer, Novartis, Teva, OMT, Astra, Boehringer, United TherapeuticsTL:Grant, personal fees and non-financial support from Actelion, Bayer, GSK and Pfizer, personal fees and non-financial support from AOP and MSD, grant and personal fee from United Therapeutics.